Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples